DCF Advisers’s Pfizer PFE Stock Holding History

DCF Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-47,000	Closed	-$1.17M	–	98
2025 Q4	$1.17M	Hold	47,000	–	–	0.31%	64
2025 Q3	$1.2M	Sell	47,000 -4,350	-8%	-$107K	0.38%	60
2025 Q2	$1.24M	Hold	51,350	–	–	0.58%	46
2025 Q1	$1.3M	Hold	51,350	–	–	0.62%	43
2024 Q4	$1.36M	Buy	51,350 +17,000	+49%	+$461K	0.66%	45
2024 Q3	$994K	Sell	34,350 -900	-3%	-$26.3K	0.4%	54
2024 Q2	$986K	Buy	35,250 +16,000	+83%	+$441K	0.51%	50
2024 Q1	$534K	Sell	19,250 -2,250	-10%	-$62.4K	0.26%	59
2023 Q4	$619K	Sell	21,500 -17,000	-44%	-$514K	0.34%	54
2023 Q3	$1.28M	Sell	38,500 -1,750	-4%	-$61.9K	0.7%	35
2023 Q2	$1.48M	Hold	40,250	–	–	0.78%	31
2023 Q1	$1.64M	Buy	40,250 +4,000	+11%	+$173K	1.01%	26
2022 Q4	$1.86M	Hold	36,250	–	–	1.26%	22
2022 Q3	$1.59M	Hold	36,250	–	–	1.02%	33
2022 Q2	$1.9M	Sell	36,250 -10,250	-22%	-$522K	1.13%	31
2022 Q1	$2.41M	Sell	46,500 -18,500	-28%	-$960K	1.05%	26
2021 Q4	$3.84M	Hold	65,000	–	–	1.56%	17
2021 Q3	$2.8M	Hold	65,000	–	–	1.23%	23
2021 Q2	$2.54M	Buy	65,000 +50,000	+333%	+$1.94M	0.9%	30
2021 Q1	$543K	Buy	+15,000	New	+$533K	0.24%	77

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

DCF Advisers's PFE Position: Q1 2026 in Review

DCF Advisers sold out of Pfizer (PFE) in Q1 2026, closing a stake of 47,000 shares — an estimated $1.17M sold.

DCF Advisers first reported a position in PFE in Q1 2021 and held it in 20 quarters. The position peaked at $3.84M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

DCF Advisers reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
DCF Advisers sold 47,000 Pfizer shares in Q1 2026, an estimated $1.17M.
DCF Advisers first reported a position in Pfizer in Q1 2021 and held it in 20 quarters.
DCF Advisers's Pfizer position peaked at $3.84M in Q4 2021.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on DCF Advisers's 13F filing for Q1 2026, filed 11 May 2026.